Accelerate Diagnostics, Inc. (AXDX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Accelerate Diagnostics, Inc. (AXDX)
Go deeper and ask any question about AXDX
Company Performance
Current Price
as of Sep 13, 2024$1.52
P/E Ratio
N/A
Market Cap
$35.99M
Description
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.
Metrics
Overview
- HQTucson, AZ
- SectorHealth Technology
- IndustryMedical Specialties
- TickerAXDX
- Price$1.52+1.33%
Trading Information
- Market Cap$35.99M
- Float58.43%
- Average Daily Volume (1m)62,101
- Average Daily Volume (3m)54,134
- EPS-$2.07
Company
- Revenue$12.23M
- Rev Growth (1yr)2.23%
- Net Income-$11.59M
- Gross Margin22.64%
- EBITDA Margin-258.84%
- EBITDA-$7.73M
- EV$59.64M
- EV/Revenue4.88
- P/EN/A
- P/S2.87
Documents
SEC Filings
Factset Street Account
Accelerate Diagnostics reports Q3 EPS $0.06 vs year-ago ($1.83) ($5.90, 0.00) (2023-11-09T21:20:55Z)
Earnings Calls
Factset